pharmalittle
Pharmalittle is a newsletter is written by Ed Silverman, a veteran health care journalist who has covered the industry for more than 20 years. Silverman’s reporting focuses on the latest news and trends in the pharmaceutical industry, including drug development, drug pricing, and the impact of the industry on patients and society.
Latest
STAT Plus: Pharmalittle: Makers of toxic cough syrups face new actions; Cassava suffers new blow over Alzheimer’s drug
STAT Plus: Pharmalittle: Life sciences deals on track to hit lowest point since 2017; EU regulators order Illumina to divest Grail
STAT Plus: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit
STAT Plus: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024
STAT Plus: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems
STAT Plus: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages
STAT Plus: Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews
All Coverage
advertisement